Plant compounds for the treatment of diabetes, a metabolic disorder: NF-κB as a therapeutic target

R Sahukari, J Punabaka, S Bhasha… - Current …, 2020 - ingentaconnect.com
Background: The prevalence of diabetes in the world population hás reached 8.8% and is
expected to rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs …
被引用次数：9 相关文章

Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target

R Sahukari, J Punabaka, S Bhasha… - Current …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The prevalence of diabetes in the world population hás reached 8.8% and is
expected to rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs …

Plant compounds for the treatment of diabetes, a metabolic disorder: NF-κB as a therapeutic target.

R Sahukari, J Punabaka, S Bhasha, VS Ganjikunta… - 2020 - cabidigitallibrary.org
Background: The prevalence of diabetes in the world population hás reached 8.8% and is
expected to rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs …

Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target.

R Sahukari, J Punabaka, S Bhasha… - Current …, 2020 - europepmc.org
Background The prevalence of diabetes in the world population hás reached 8.8% and is
expected to rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs …

Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target

R Sahukari, J Punabaka, S Bhasha… - Current …, 2020 - hero.epa.gov
The prevalence of diabetes in the world population hás reached 8.8% and is expected to
rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs against …